ESTRELLA IMMUNOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.6M | $45.8M | $478.9K |
| FY2022 | $2.7M | $9.7M | $4.1M |
| FY2023 | $9.8M | $3.0M | $2.5M |
| FY2024 | $180.7K | $4.5M | $4.2M |
| FY2025 | $13.5M | $3.2M | $1.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.6M | $45.8M | $478.9K |
| FY2022 | $2.7M | $9.7M | $4.1M |
| FY2023 | $9.8M | $3.0M | $2.5M |
| FY2024 | $180.7K | $4.5M | $4.2M |
| FY2025 | $13.5M | $3.2M | $1.4M |